Bondi Sands Broad Spectrum Hydra UV Protect SPF 70 Sunscreen Lotion

Bondi Sands Broad Spectrum Hydra UV Protect SPF 70 Sunscreen by

Drug Labeling and Warnings

Bondi Sands Broad Spectrum Hydra UV Protect SPF 70 Sunscreen by is a Otc medication manufactured, distributed, or labeled by Baxter Laboratories Pty. Ltd.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

BONDI SANDS BROAD SPECTRUM HYDRA UV PROTECT SPF 70 SUNSCREEN- avobenzone, homosalate, octisalate, octocrylene lotion 
Baxter Laboratories Pty. Ltd.

----------

Bondi Sands Broad Spectrum Hydra UV Protect SPF 70 Sunscreen Lotion

Active Ingredients

Avobenzone 3%, Homosalate 15%, Octisalate 5%, Octocrylene 10%

Purpose

Sunscreen

Uses

  • Helps prevent sunburn
  • Higher SPF gives more sunburn protection
  • If used as directed with other sun protection measures ( see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.
  • Retains SPF after 80 minutes of activity in the water.

Warnings

For external use only

Do not use on damaged or broken skin.

Stop use and ask a doctor if rash or irritation develops and lasts.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

When using this product

keep out of eyes. Rinse with water to remove.

Directions

  • Apply liberally 15 minutes before sun exposure.
  • Reapply:
  • after 80 minutes of swimming or sweating
  • immediately after towel drying
  • at least every 2 hours
  • Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
  • Limit time in the sun, especially from 10 a.m.- 2 p.m.
  • Wear long-sleeved shirts, pants, hats, and sunglasses.

Other information

  • Protect the product in this container from excessive heat and direct sun.
  • You may report a serious adverse reaction to 888-266-0772; Monday – Friday, 9 am – 5 pm.

Inactive Ingredients

Water, Beeswax, Aloe Barbadensis Leaf Juice, Cetearyl Alcohol, Cyclopentasiloxane, Isopropyl Palmitate, Ceteareth-20, Cyclohexasiloxane, Hydroxyacetophenone, Benzyl Alcohol, Phenoxyethanol, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Sodium Stearoyl Glutamate, Tocopheryl Acetate, Sodium Carrageenan, Sodium Chloride, Aminomethyl Propanediol.

Questions?

888-266-0772 or visit bondisands.com

Product Packaging

bondi sands

The Australian tan

BROAD SPECTRUM

HYDRA

UV PROTECT

SPF 70

SUNSCREEN LOTION

VERY WATER RESISTANT 80 MINUTES

PLANT BASED HYDRATION

REEF FRIENDLY

Australian Made

5.07 FL. OZ. (150mL)

hydra lotion

BONDI SANDS BROAD SPECTRUM HYDRA UV PROTECT SPF 70 SUNSCREEN 
avobenzone, homosalate, octisalate, octocrylene lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 70157-018
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE30 mg  in 1 mL
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE100 mg  in 1 mL
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE150 mg  in 1 mL
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE50 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
CYCLOMETHICONE 6 (UNII: XHK3U310BA)  
POLYOXYL 20 CETOSTEARYL ETHER (UNII: YRC528SWUY)  
HYDROXYACETOPHENONE (UNII: G1L3HT4CMH)  
ISOPROPYL PALMITATE (UNII: 8CRQ2TH63M)  
SODIUM STEAROYL GLUTAMATE (UNII: 65A9F4P024)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
AMINOMETHYL PROPANEDIOL (UNII: CZ7BU4QZJZ)  
WATER (UNII: 059QF0KO0R)  
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
CARRAGEENAN (UNII: 5C69YCD2YJ)  
YELLOW WAX (UNII: 2ZA36H0S2V)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
BENZYL ALCOHOL (UNII: LKG8494WBH)  
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 70157-018-01150 mL in 1 TUBE; Type 0: Not a Combination Product08/05/202108/05/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02008/05/202108/05/2021
Labeler - Baxter Laboratories Pty. Ltd. (740537709)

Revised: 3/2026
Document Id: 4c755c87-729f-cb2f-e063-6294a90a85ba
Set id: 0fdf19e5-9df2-20ed-e063-6394a90a3377
Version: 2
Effective Time: 20260307